We found three- to eight-fold higher levels of PODXL expression in malignant cells compared to their normal B-cell counterparts in two out of five cases of follicular lymphoma and one out of three cases of chronic lymphocytic leukemia/small lymphocytic lymphoma. Here, PODXL is linked to B-cell chronic lymphocytic leukemia.